Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study

BACKGROUND: Etanercept (ETN) is widely used tumour necrosis factor (TNF) blocker in the treatment of juvenile idiopathic arthritis (JIA) when traditional synthetic disease modifying antirheumatic drug (sDMARD) therapy is not sufficient. There is limited information about the effects of methotrexate...

Descripción completa

Detalles Bibliográficos
Autores principales: Levälampi, Tiina, Kärki, Johanna, Rebane, Katariina, Vähäsalo, Paula, Malin, Merja, Kröger, Liisa, Grönlund, Minna-Maija, Backström, Maria, Pohjankoski, Heini, Kautiainen, Hannu, Jokiranta, Sakari, Aalto, Kristiina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035115/
https://www.ncbi.nlm.nih.gov/pubmed/36949461
http://dx.doi.org/10.1186/s12969-023-00801-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035115/
https://www.ncbi.nlm.nih.gov/pubmed/36949461
http://dx.doi.org/10.1186/s12969-023-00801-2

Ejemplares similares